quantdetect

Ten OTS-Assay-related studies were presented at the 10th Liquid Biopsy meeting (Kyoto).

Nishizuka gave a talk in Session 2 at the 10th Liquid Biopsy 2026 meeting, sponsored by Quantdetect, Inc (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the Evening Seminar of the 21st TR Workshop of the Japanese Association for Molecular Target Therapy of Cancer (Tokyo).

Nishizuka gave a Platform Presentation at the American Molecular Pathology Annual Meeting & Expo (Boston, USA).

Nishizuka attended the General Assembly of the European Liquid Biopsy Society (Madrid, Spain).

Hayato Hiraki Ph.D., from Iwate Medical University, Jain and Nishizuka from Quantdetect gave a talk at the 84th Annual Meeting of the Japanese Cancer Association (Kanazawa).

Nishizuka gave a talk on the OTS assay at the 45th Annual Meeting of the Japanese Society of Molecular Tumor Markers (Kanazawa).

Takeshi Iwaya, M.D., Ph.D., from the Department of Clinical Oncology, Iwate Medical University, delivered a seminar on OTS Assay at the Miyagi Cancer Center (Natori).

A movie clip by Dr. Endo from the Department of Clinical Oncology, Iwate Medical University, entitled “A New Standard for Optimizing ICI Therapy through ctDNA Monitoring: The Challenge from Iwate Medical University”, has been released on the “Japan Esophageal Society – Shokudo Channel.”

Nishizuka held a seminar at Miyagi Cancer Center (Natori).